An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy
Article Details
Journal Info
Journal of the American Chemical Society
American Chemical Society
Authors (14)
Youmei Xiao
School of Pharmaceutical Sciences (Shenzhen)
Xiuman Zhou
Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital
Xiaoshuang Niu
School of Pharmaceutical Sciences (Shenzhen)
Xiaoyun Ye
School of Pharmaceutical Sciences (Shenzhen)
Danhong Chen
School of Pharmaceutical Sciences (Shenzhen)
Qingyu Dong
School of Pharmaceutical Sciences (Shenzhen)
Zhuoying He
School of Pharmaceutical Sciences (Shenzhen)
Xin Yang
Mengfan Wang
School of Pharmaceutical Sciences (Shenzhen)
Wenxuan Zeng
School of Pharmaceutical Sciences (Shenzhen)
Ye Su
School of Pharmaceutical Sciences (Shenzhen)
Feiyu Luo
School of Pharmaceutical Sciences (Shenzhen)
Juan Liu
Yanfeng Gao
School of Pharmaceutical Sciences (Shenzhen)